Anti-HTLV-1 Capsid protein p24 Polyclonal Antibody
The Anti-HTLV-1 Capsid protein p24 Polyclonal Antibody is a highly specific and sensitive tool for the detection and analysis of the Human T-cell Leukemia Virus Type 1 (HTLV-1). This polyclonal antibody is produced through immunization of rabbits with a synthetic peptide corresponding to the C-terminal region of the HTLV-1 Capsid protein p24.
Biological Function:
The HTLV-1 Capsid protein p24 is a structural protein that plays a crucial role in the assembly and maturation of the virus. It is also involved in viral replication and immune evasion. The Anti-HTLV-1 Capsid protein p24 Polyclonal Antibody binds specifically to this protein, allowing for the detection and study of HTLV-1.
Main Applications:
This antibody is ideal for use in various research applications, including Western blotting, immunohistochemistry, and ELISA. It can also be used for the detection of HTLV-1 in patient samples, making it a valuable tool for diagnostic purposes.
Experimental Use Cases:
The Anti-HTLV-1 Capsid protein p24 Polyclonal Antibody has been used in several studies to investigate the role of HTLV-1 in diseases such as adult T-cell leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis. It has also been used to study the immune response to HTLV-1 infection and the potential for developing vaccines against the virus.
With its high specificity and sensitivity, this antibody is an essential tool for researchers studying HTLV-1 and its associated diseases. It provides reliable and accurate results, allowing for a better understanding of the virus and its impact on human health.
In conclusion, the Anti-HTLV-1 Capsid protein p24 Polyclonal Antibody is a valuable asset for biotech research, offering a wide range of applications and use cases. Its ability to specifically bind to the HTLV-1 Capsid protein p24 makes it a powerful tool for the detection and analysis of this virus. Invest in this antibody today and take your research to the next level.
There are no reviews yet.